Back to Search
Start Over
Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing.
- Source :
- Medicine; 12/15/2023, Vol. 102 Issue 50, pe36387-e36387, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00257974
- Volume :
- 102
- Issue :
- 50
- Database :
- Complementary Index
- Journal :
- Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 175570987
- Full Text :
- https://doi.org/10.1097/MD.0000000000036387